Form 10-Q · Quarterly report
Fortive 10-Q, filed Jul 29, 2026
- Filed
- CIK
- 0001659166
- Accession no.
- 0001659166-26-000034
Summary
Fortive's quarterly report covers its continuing operations in Intelligent Operating Solutions and Advanced Healthcare Solutions after it completed the separation of its former Precision Technologies segment on June 28, 2025 by distributing all Ralliant Corporation common stock to shareholders, which is now reported as a discontinued operation. The filing also sets out management's forward-looking statements and risk factors, including trade and tariff policy, supply chain, litigation, tax, and separation-related risks.
Key points
- Fortive's continuing operations are organized into two segments: Intelligent Operating Solutions and Advanced Healthcare Solutions.
- The separation of Precision Technologies into Ralliant is presented as a discontinued operation in all periods shown in the consolidated condensed financial statements.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Fortive Corporation (“Fortive,” the “Company,” “we,” “us,” or “our”) innovates essential technologies to keep our world safe and productive. Our strategic segments - Intelligent Operating Solutions (“IOS”) and Advanced Healthcare Solutions (“AHS”) - include iconic inventor brands with leading positions in their markets. Our businesses design, develop, manufacture, and market products, software, and services, building upon leading brand names, innovative technologies, and strong market positions. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.